Skip to content

Dextroamphetamine

Published: July 26, 2026Updated: August 24, 2026

Dextroamphetamine is a central nervous system stimulant that increases dopamine and norepinephrine levels in the brain. It is primarily prescribed to treat attention deficit hyperactivity disorder (ADHD) in both children and adults, helping improve focus, attention, and impulse control.

Quick summary

Dextroamphetamine is a stimulant medication used to treat ADHD and narcolepsy by increasing brain chemicals that control focus and attention.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
N06BA02
RxNorm
3288
Generic
Dextroamphetamine
Class
atc-n06
Brands
Zenzedi, Dexedrine, Mydayis, Xelstrym, ProCentra, Adderall
Availability
rx
Pregnancy
C
Lactation
caution
Routes
oral
Forms
capsule, tablet, solution
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
10mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
5mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
5mg once daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity in most adults, though toxicity varies based on individual factors
Chronic overdose: Prolonged use leading to tolerance escalation and cumulative cardiovascular strain
Immediate actions
airway protection, activated charcoal if within 1-2 hours of ingestion, supportive care, benzodiazepines for agitation
Antidote
no specific antidote(supportive care is mainstay of treatment)
Poison Control: 1-800-222-1222

Special Populations

8 groups
✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
C
Dose Adjustment

discontinue before third trimester if possible

Key Recommendations

avoid use near term due to risk of premature labor and neonatal effects

Monitor

fetal growth monitoring and uterine activity tracking

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
contraindicated
FDA Category
C
Dose Adjustment

discontinue breastfeeding or avoid drug

Key Recommendations

dextroamphetamine excreted in breast milk - breastfeeding not recommended

Monitor

monitor infant for irritability, poor weight gain, and sleep disturbances

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pediatric_age

children 3 12 years
caution
FDA Category
C
Dose Adjustment

start at lowest dose, titrate slowly

Key Recommendations

monitor growth parameters closely; may cause growth suppression

Monitor

regular height/weight monitoring, cardiovascular monitoring

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly 65 years and older
caution
FDA Category
C
Dose Adjustment

start at lowest dose, reduce maintenance dose by 50%

Key Recommendations

use with caution due to increased sensitivity to cardiovascular effects

Monitor

monitor blood pressure, heart rate, and for signs of agitation or confusion

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild renal impairment
caution
FDA Category
C
Dose Adjustment

no adjustment needed for mild impairment

Key Recommendations

monitor renal function during treatment

Monitor

periodic monitoring of renal function

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe renal impairment
caution
FDA Category
C
Dose Adjustment

reduce dose by 50% or use with caution

Key Recommendations

significant renal impairment requires dose reduction

Monitor

frequent monitoring of drug levels and renal function

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

moderate hepatic impairment
caution
FDA Category
C
Dose Adjustment

start at lower dose

Key Recommendations

use with caution in hepatic impairment

Monitor

monitor for increased side effects

Use with caution and monitor for adverse effects.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:Central nervous system stimulant

Amphetamine-type stimulant

usageFDA
2023

Common uses

Value:ADHD, narcolepsy

Therapeutic indications

regulatoryDEA
2023

Controlled substance schedule

Value:Schedule II

Legal classification

prescribingFDA
2023

First FDA approval

Value:1975

Initial market authorization for Dexedrine

Dextroamphetamine is FDA-approved for treating ADHD in patients 3 years and older, as well as narcolepsy—a sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks.

As a CNS stimulant, dextroamphetamine increases the release and blocks the reuptake of neurotransmitters dopamine and norepinephrine in brain regions responsible for attention, focus, and impulse control, resulting in improved concentration and behavioral regulation.

Dextroamphetamine is a Schedule II controlled substance with high abuse potential and risk of dependence. Common side effects include decreased appetite, weight loss, insomnia, increased heart rate, and elevated blood pressure. It may cause sudden death in patients with pre-existing cardiac abnormalities. Regular monitoring of growth, cardiovascular health, and mental status is recommended during treatment.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy